SCHEMBL8937434

SCHEMBL8937434

CCCOc1cccc(/C(=C/C(=O)O)c2cccc(Cl)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.60
MAPT P10636 4/20 0.52
TP53 P04637 2/20 0.52
NR1H4 Q96RI1 1/20 0.49
KDM4E B2RXH2 2/20 0.48
NR4A2 P43354 1/20 0.48
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KAT6A Q92794 1/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
ADRB3 P13945 1/20 0.45
PLA2G4B P0C869 1/20 0.44
SMPD1 P17405 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937306 1.00 KMT2A (0.60) KMT2AMAPTTP53NR1H4KDM4E
SCHEMBL8937303 1.00 KMT2A (0.60) KMT2AMAPTTP53NR1H4KDM4E
SCHEMBL8937571 0.91 MAPT (0.60) KMT2AMAPTTP53NR1H4MAOA
SCHEMBL8937565 0.91 MAPT (0.60) KMT2AMAPTTP53NR1H4MAOA
SCHEMBL8937615 0.91 MAPT (0.60) KMT2AMAPTTP53NR1H4MAOA
SCHEMBL8937464 0.90 KMT2A (0.67) KMT2AMAPTTP53NR1H4ALDH1A1
SCHEMBL8937469 0.90 KMT2A (0.67) KMT2AMAPTTP53NR1H4ALDH1A1
SCHEMBL8937473 0.90 KMT2A (0.67) KMT2AMAPTTP53NR1H4ALDH1A1
SCHEMBL8937425 0.83 NPC1 (0.56) KMT2AMAPTTP53MAOBALDH1A1
SCHEMBL8937419 0.83 NPC1 (0.56) KMT2AMAPTTP53MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed